Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson's disease
Autophagy has been shown to play an important role in Parkinson's disease. We hypothesized that skin-derived precursor cells exhibit neuroprotective effects in Parkinson's disease through affecting autophagy. In this study, 6-hydroxydopamine-damaged SH-SY5Y cells were pretreated with a culture medium containing skin-derived precursors differentiated into Schwann cells (SKP-SCs). The results showed that the SKP-SC culture medium remarkably enhanced the activity of SH-SY5Y cells damaged by 6-hydroxydopamine, reduced excessive autophagy, increased tyrosine hydroxylase expression, reduced α-synuclein expression, reduced the autophagosome number, and activated the PI3K/AKT/mTOR pathway. Autophagy activator rapamycin inhibited the effects of SKP-SCs, and autophagy inhibitor 3-methyladenine had the opposite effect. These findings confirm that SKP-SCs modulate the PI3K/AKT/mTOR pathway to inhibit autophagy, thereby exhibiting a neuroprotective effect in a cellular model of Parkinson's disease. This study was approved by the Animal Ethics Committee of Laboratory Animal Center of Nantong University (approval No. S20181009-205) on October 9, 2018.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Neural regeneration research - 17(2022), 6 vom: 13. Juni, Seite 1357-1363 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yan, Jia-Nan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alpha-synuclein |
---|
Anmerkungen: |
Date Revised 15.12.2021 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.4103/1673-5374.327353 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM333203186 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM333203186 | ||
003 | DE-627 | ||
005 | 20231225221153.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4103/1673-5374.327353 |2 doi | |
028 | 5 | 2 | |a pubmed24n1110.xml |
035 | |a (DE-627)NLM333203186 | ||
035 | |a (NLM)34782582 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yan, Jia-Nan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson's disease |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 15.12.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Autophagy has been shown to play an important role in Parkinson's disease. We hypothesized that skin-derived precursor cells exhibit neuroprotective effects in Parkinson's disease through affecting autophagy. In this study, 6-hydroxydopamine-damaged SH-SY5Y cells were pretreated with a culture medium containing skin-derived precursors differentiated into Schwann cells (SKP-SCs). The results showed that the SKP-SC culture medium remarkably enhanced the activity of SH-SY5Y cells damaged by 6-hydroxydopamine, reduced excessive autophagy, increased tyrosine hydroxylase expression, reduced α-synuclein expression, reduced the autophagosome number, and activated the PI3K/AKT/mTOR pathway. Autophagy activator rapamycin inhibited the effects of SKP-SCs, and autophagy inhibitor 3-methyladenine had the opposite effect. These findings confirm that SKP-SCs modulate the PI3K/AKT/mTOR pathway to inhibit autophagy, thereby exhibiting a neuroprotective effect in a cellular model of Parkinson's disease. This study was approved by the Animal Ethics Committee of Laboratory Animal Center of Nantong University (approval No. S20181009-205) on October 9, 2018 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a PI3K/AKT/mTOR pathway | |
650 | 4 | |a Parkinson's disease | |
650 | 4 | |a alpha-synuclein | |
650 | 4 | |a autophagosomes | |
650 | 4 | |a autophagy | |
650 | 4 | |a neural regeneration | |
650 | 4 | |a neuroprotection | |
650 | 4 | |a skin-derived precursor Schwann cells | |
700 | 1 | |a Zhang, Hai-Ying |e verfasserin |4 aut | |
700 | 1 | |a Li, Jun-Rui |e verfasserin |4 aut | |
700 | 1 | |a Chen, Ying |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Yong-Cheng |e verfasserin |4 aut | |
700 | 1 | |a Shen, Jia-Bing |e verfasserin |4 aut | |
700 | 1 | |a Ke, Kai-Fu |e verfasserin |4 aut | |
700 | 1 | |a Gu, Xiao-Su |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neural regeneration research |d 2012 |g 17(2022), 6 vom: 13. Juni, Seite 1357-1363 |w (DE-627)NLM234805757 |x 1673-5374 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2022 |g number:6 |g day:13 |g month:06 |g pages:1357-1363 |
856 | 4 | 0 | |u http://dx.doi.org/10.4103/1673-5374.327353 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2022 |e 6 |b 13 |c 06 |h 1357-1363 |